Clinical Studies of peptide bioregulators of the CYTOMAX AND CYTOGEN class



Reports on the results of clinical studies of peptide bioregulators of the CYTOMAX AND
CYTOGEN class.

Introduction
The raging of the body is one of the most mysterious and relevant topics in modern medicine. For
centuries, scientists worldwide have been trying to answer these questions: how to prolong youth?
How to maintain good health? How to stay active for a long time? In Russia, this issue has been resolved
by the St. Petersburg Institute of Bioregulation and Gerontology under the guidance of Professor V.
Khavinson. As a result of numerous clinical studies, physiologically active proteins have been discovered
- peptides, which help the body naturally restore itself.

In the new edition, we combined all the scientifically proven results of the use of peptide bioregulators
of the Cytomax class (21 geroprotectors) and Cytogenes (6 geroprotectors). These studies confirm
that peptides of natural origin («Cytomaxes») harmonize metabolic processes in human cells. In the
long term, this reduces the risk of cancer, slows down premature aging, and increases life expectancy.
In turn, «Cytogenes», synthesized from natural amino acids, have a faster effect at the initial stage,
starting up the function of restoring internal organs. Physiologically active short peptides should be
used at any age to maintain a normal level of metabolic processes, prevent and treat various diseases,
for rehabilitation after serious illnesses, injuries, or surgeries, and for slowing down the body’s aging
process. Both classes of Peptides bioregulators have no side effects, as they contain peptides, which
are part of the human body.

For your convenience, we have added a section - recommendations for use.

Attached Files
brochure_clinical_researches_citomaxes_citogens_english.pdf
404kb